Literature DB >> 31673463

Transfusion-Associated Acute Lung Injury following Donor Granulocyte Transfusion in Two Pediatric Patients.

Didar Arslan1, Dincer Yildizdas1, Ozden Ozgur Horoz1, Nagehan Aslan1, Goksel Leblebisatan2.   

Abstract

Transfusion-associated acute lung injury (TRALI) is one of the complications seen due to transfusion. Hypoxemia and bilateral pulmonary infiltration in posteroanterior chest roentgenogram is seen in all cases during transfusion or within the first 6 hours; fever, hypotension, and pink frothy bleeding from endotracheal tube may also be seen. It can be seen following the administration of any blood product. The management strategies for TRALI include withholding the transfusion, positive pressure breathing support, and diuretics. There are few reported cases of TRALI occurring following donor granulocyte transfusion (DGT). In this article, we discuss two cases of TRALI following DGT transfusion. © Thieme Medical Publishers.

Entities:  

Keywords:  TRALI; donor granulocyte transfusion; pediatric

Year:  2019        PMID: 31673463      PMCID: PMC6821522          DOI: 10.1055/s-0039-1694991

Source DB:  PubMed          Journal:  J Pediatr Intensive Care        ISSN: 2146-4626


  19 in total

1.  Designing and testing a computer-based screening system for transfusion-related acute lung injury.

Authors:  Heather E Finlay; Lydia Cassorla; John Feiner; Pearl Toy
Journal:  Am J Clin Pathol       Date:  2005-10       Impact factor: 2.493

Review 2.  Transfusion-related acute lung injury (TRALI): a serious adverse event of blood transfusion.

Authors:  J Bux
Journal:  Vox Sang       Date:  2005-07       Impact factor: 2.144

Review 3.  Pathophysiology of hemolytic transfusion reactions.

Authors:  Robertson D Davenport
Journal:  Semin Hematol       Date:  2005-07       Impact factor: 3.851

4.  Risk Factors and Clinical Outcomes Associated with Perioperative Transfusion-associated Circulatory Overload.

Authors:  Leanne Clifford; Qing Jia; Arun Subramanian; Hemang Yadav; Darrell R Schroeder; Daryl J Kor
Journal:  Anesthesiology       Date:  2017-03       Impact factor: 7.892

5.  Prospective study on the clinical course and outcomes in transfusion-related acute lung injury*.

Authors:  Mark R Looney; Nareg Roubinian; Ognjen Gajic; Michael A Gropper; Rolf D Hubmayr; Clifford A Lowell; Peter Bacchetti; Gregory Wilson; Monique Koenigsberg; Deanna C Lee; Ping Wu; Barbara Grimes; Philip J Norris; Edward L Murphy; Manish J Gandhi; Jeffrey L Winters; David C Mair; Randy M Schuller; Nora V Hirschler; Rosa Sanchez Rosen; Michael A Matthay; Pearl Toy
Journal:  Crit Care Med       Date:  2014-07       Impact factor: 7.598

6.  Alloimmunization after granulocyte transfusions.

Authors:  D F Stroncek; K Leonard; G Eiber; H L Malech; J I Gallin; S F Leitman
Journal:  Transfusion       Date:  1996 Nov-Dec       Impact factor: 3.157

7.  Experimental prestorage filtration removes antibodies and decreases lipids in RBC supernatants mitigating TRALI in vivo.

Authors:  Christopher C Silliman; Marguerite R Kelher; Samina Y Khan; Monica LaSarre; F Bernadette West; Kevin J Land; Barbara Mish; Linda Ceriano; Samuel Sowemimo-Coker
Journal:  Blood       Date:  2014-04-18       Impact factor: 22.113

8.  Transfusion-related acute lung injury in the critically ill: prospective nested case-control study.

Authors:  Ognjen Gajic; Rimki Rana; Jeffrey L Winters; Murat Yilmaz; Jose L Mendez; Otis B Rickman; Megan M O'Byrne; Laura K Evenson; Michael Malinchoc; Steven R DeGoey; Bekele Afessa; Rolf D Hubmayr; S Breanndan Moore
Journal:  Am J Respir Crit Care Med       Date:  2007-07-12       Impact factor: 21.405

9.  TRALI after the transfusion of cross-match-positive granulocytes.

Authors:  Ulrich J Sachs; Jürgen Bux
Journal:  Transfusion       Date:  2003-12       Impact factor: 3.157

10.  Risk factors and outcome of transfusion-related acute lung injury in the critically ill: a nested case-control study.

Authors:  Alexander P J Vlaar; Jan M Binnekade; David Prins; Danielle van Stein; Jorrit J Hofstra; Marcus J Schultz; Nicole P Juffermans
Journal:  Crit Care Med       Date:  2010-03       Impact factor: 7.598

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.